Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Janowsky

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Biochemical Pharmacology|October 22, 2020
Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptorsAmy J Eshleman, Shanthi Nagarajan, Katherine M Wolfrum, et al.
Biochemical Pharmacology|April 16, 2013
Substituted methcathinones differ in transporter and receptor interactionsAmy J Eshleman, Katherine M Wolfrum, Meagan G Hatfield, et al.
Psychopharmacology|November 7, 2018
Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transportersAmy J Eshleman, Shanthi Nagarajan, Katherine M Wolfrum, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2016
Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and ReleaseAmy J Eshleman, Katherine M Wolfrum, John F Reed, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 13, 2018
Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake InhibitorMichelle G Baladi, Michael J Forster, Michael B Gatch, et al.
Journal of Medicinal Chemistry|January 19, 2007
Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporterMark Froimowitz, Yonghong Gu, Les A Dakin, et al.
Journal of Medicinal Chemistry|September 22, 2018
Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine TransporterBrian A Provencher, Amy J Eshleman, Robert A Johnson, et al.
Psychopharmacology|February 4, 2014
Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitroAaron Janowsky, Amy J Eshleman, Robert A Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 10, 2020
Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and TransportersRandy Torralva, Amy J Eshleman, Tracy L Swanson, et al.
Journal of Medicinal Chemistry|March 21, 2017
Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium SymportersDilip K Tosh, Aaron Janowsky, Amy J Eshleman, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Biochemical Pharmacology|October 22, 2020
Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptorsAmy J Eshleman, Shanthi Nagarajan, Katherine M Wolfrum, et al.
Biochemical Pharmacology|April 16, 2013
Substituted methcathinones differ in transporter and receptor interactionsAmy J Eshleman, Katherine M Wolfrum, Meagan G Hatfield, et al.
Psychopharmacology|November 7, 2018
Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transportersAmy J Eshleman, Shanthi Nagarajan, Katherine M Wolfrum, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2016
Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and ReleaseAmy J Eshleman, Katherine M Wolfrum, John F Reed, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 13, 2018
Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake InhibitorMichelle G Baladi, Michael J Forster, Michael B Gatch, et al.
Journal of Medicinal Chemistry|January 19, 2007
Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporterMark Froimowitz, Yonghong Gu, Les A Dakin, et al.
Journal of Medicinal Chemistry|September 22, 2018
Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine TransporterBrian A Provencher, Amy J Eshleman, Robert A Johnson, et al.
Psychopharmacology|February 4, 2014
Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitroAaron Janowsky, Amy J Eshleman, Robert A Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 10, 2020
Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and TransportersRandy Torralva, Amy J Eshleman, Tracy L Swanson, et al.
Journal of Medicinal Chemistry|March 21, 2017
Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium SymportersDilip K Tosh, Aaron Janowsky, Amy J Eshleman, et al.
Pageof 7